Page last updated: 2024-08-22

platinum and Drug-Induced Cochlear Toxicity

platinum has been researched along with Drug-Induced Cochlear Toxicity in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's10 (100.00)2.80

Authors

AuthorsStudies
Brigato, F; De Corso, E; Fetoni, AR; Galli, J; Lucidi, D; Ruggiero, A; Scarano, E; Sergi, B1
Ehlert, K; Graham, MA; Heinze, B; Swanepoel, D1
Chadha, S; Dillard, LK; Fullerton, AM; Lopez-Perez, L; Martinez, RX; McMahon, CM1
Ahmed, R; Attia, M; Hanna, D; Kamal, NM; Oshi, MAM; Rifky, E; Sherief, LM1
Akeroyd, MA; Baguley, DM; Pearson, SE; Phillips, OR1
Chong, WQ; Goh, BC; Hong, DZ; Kwa, ED; Loh, KS; Loh, WS; Ong, TCC; Tan, EC; Tan, HTA; Tay, JK; Timbadia, DP1
Navarro-Ruiz, NE1
Cunningham, LL; Fernandez, KA; Fitzgerald, TS; Gersten, BK1
Burotto, M; Caglevic, C; Cortés Fuentes, IA; Frelinghuysen, M; Gormaz, JG; Retamal, MA1
Allison, WT; Babolmorad, G; Bhavsar, AP; Delyea, C; Domingo, IK; Latif, A; Pollock, NM; Rieger, AM1

Reviews

4 review(s) available for platinum and Drug-Induced Cochlear Toxicity

ArticleYear
Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis.
    Cancer epidemiology, 2022, Volume: 79

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Hearing Loss; Humans; Neoplasms; Ototoxicity; Platinum

2022
The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review.
    Journal of cancer survivorship : research and practice, 2023, Volume: 17, Issue:1

    Topics: Adult; Antineoplastic Agents; Cancer Survivors; Carboplatin; Child; Cisplatin; Hearing Loss; Humans; Neoplasms; Ototoxicity; Platinum; Quality of Life; Tinnitus

2023
Systematic Review and Meta-Analysis of the Influence of Genetic Variation on Ototoxicity in Platinum-Based Chemotherapy.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2023, Volume: 168, Issue:6

    Topics: Acid Anhydride Hydrolases; Antineoplastic Agents; Cisplatin; Humans; Ototoxicity; Platinum; Polymorphism, Single Nucleotide; Xeroderma Pigmentosum Group D Protein

2023
Prevention of Platinum-Induced Hearing Loss in Children with Cancer.
    The American journal of nursing, 2020, Volume: 120, Issue:6

    Topics: Amifostine; Humans; Neoplasms; Ototoxicity; Platinum; Practice Guidelines as Topic; Thiosulfates

2020

Other Studies

6 other study(ies) available for platinum and Drug-Induced Cochlear Toxicity

ArticleYear
Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2022, Volume: 279, Issue:10

    Topics: Antineoplastic Agents; Carboplatin; Child; Cisplatin; Follow-Up Studies; Hearing Loss; Humans; Ototoxicity; Platinum; Platinum Compounds

2022
Surveillance for ototoxicity in platinum-based chemotherapy using mobile health audiometry with extended high frequencies.
    The Journal of laryngology and otology, 2023, Volume: 137, Issue:1

    Topics: Antineoplastic Agents; Audiometry; Audiometry, Pure-Tone; Auditory Threshold; Cisplatin; Humans; Longitudinal Studies; Ototoxicity; Platinum

2023
Platinum-induced ototoxicity in pediatric cancer survivors: GSTP1 c.313A>G variant association.
    Medicine, 2022, Nov-11, Volume: 101, Issue:45

    Topics: Cancer Survivors; Carboplatin; Child; Cisplatin; Cross-Sectional Studies; Deafness; Glutathione S-Transferase pi; Hearing Loss; Humans; Neoplasms; Ototoxicity; Platinum

2022
Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents.
    Journal of the Association for Research in Otolaryngology : JARO, 2020, Volume: 21, Issue:4

    Topics: Animals; Antineoplastic Agents; Cisplatin; Cochlea; Female; Male; Mice, Inbred CBA; Ototoxicity; Platinum

2020
Potential use of n-3 PUFAs to prevent oxidative stress-derived ototoxicity caused by platinum-based chemotherapy.
    Free radical biology & medicine, 2020, 11-20, Volume: 160

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Fatty Acids, Omega-3; Humans; Ototoxicity; Oxidative Stress; Platinum

2020
Toll-like receptor 4 is activated by platinum and contributes to cisplatin-induced ototoxicity.
    EMBO reports, 2021, 05-05, Volume: 22, Issue:5

    Topics: Antineoplastic Agents; Cisplatin; Humans; Neoplasms; Ototoxicity; Platinum; Toll-Like Receptor 4

2021